Skip to main content
SpringerLink
Log in

Chirurgie

  • Chapter
Bronchuscarcinom

Part of the book series: Onkologie heute ((ONKOLOGIE))

  • 19 Accesses

Zusammenfassung

Beim Bronchuscarcinom wird eine Gesamtüberlebensrate von 15% angegeben. Neben der histologischen Klassifikation ist das Stadium zum Zeitpunkt der Diagnose der bestimmende prognostische Parameter. Die 5-Jahresüberlebensrate beträgt im Stadium I 70%, im Stadium TT 35%, Stadium III A 20% und im Stadium III B nur noch 6%. Daraus folgt, daß nur Patienten in einem frühen Stadium eine realistische Heilungschance haben. Die Anstrengungen zur Verbesserung der Prognose zielen somit einerseits auf cinc rechtzeitige Früherkennung durch Selektion von Risikogruppen und Definition von sinnvollen Screening-Parametern und anderseits vor allem auf effizientere Therapieformen bei fortgeschrittenen Stadien. Die Chirurgie spielt beim nicht-kleinzelligen Bronchuscarcinom (NSCLC) nach wie vor die wichtigste Rolle in der Behandlung, aber auch im Frühstadium des kleinzelligen Bronchuscarcinoms (SCLC) hat die chirurgische Resektion ihren Platz innerhalb der multimodalen Behandlungsstrategie. Wegen der unterschiedlichen Häufigkeit und Gewichtung wird im folgenden primär auf das NSCLC eingegangen. Im Anschluß wird gesondert die Behandlung des SCLC aus chirurgischer Sicht dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Carretta A, Zannini P, Puglisi A, Chiesa G, Vanzulli A, Bianchi A, Fumagalli A, Bianco S (1999) Improvement of pulmonary function after lobectomy for non-small cell lung cancer in emphysematous patients. Eur J Cardiothorac Surg 15: 602–607.

    Article  PubMed  CAS  Google Scholar 

  2. D’Amico TA, Massey M, Herdon 1IJE, Morre M, Harpole Jr DH (1999) A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117: 736–743.

    Article  PubMed  Google Scholar 

  3. De Leyn P, Vansteenkiste J, Cuypers P, Deneffe G, Van Raemdonck D, Coosemans W, Verschakclen J, Lerut T (1997) Role of cervical mediastinoscopy in staging of nonsmall cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiochorac Surg 12: 706–712.

    Article  Google Scholar 

  4. Dillman RD, Seargren SL, Proper K, et al. (1990) A randomized trial of induction chemotherapy plus high-dose radiation vs radiation alone in stage III NSCLC. N Engl J Med 323: 940–945.

    Article  PubMed  CAS  Google Scholar 

  5. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hypcrfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 16: 622–634.

    PubMed  CAS  Google Scholar 

  6. Elias AD (1997) Small cell lung cancer. State-of-the-art therapy in 1996. Chest 112: 251S-258S.

    Google Scholar 

  7. Felip E, Moreno I, Canela M, et al. (1997) Spanish Lung Cancer Group randomized trial of preoperative chemotherapy (cisplatin either 50 mg/m2 or 100 mg/m2) in stage IIIA (N2) non-small-cell lung cancer. 8th World Conference on Lung Cancer, Dublin, Ireland.

    Google Scholar 

  8. Fukuse T, Wada H, Hitomi S (1997) Extended operation for non-small cell lung cancer invading great vessels and left atrium. Eur J Cardiothorac Surg 11: 664–669.

    Article  PubMed  CAS  Google Scholar 

  9. Ginsberg R, Vokes EE, Raben A (1997) Non-small cell lung cancer. In: De Vita Jr VT, Hellman W, Rosenberg SA (Hrsg.): Cancer-Principles and Practice of Oncology, S. 858–910. Lippincott, Philadelphia, PA.

    Google Scholar 

  10. Graham NJA, Chan KJM, Pastorino U, Goldstraw P (1999) Systematic nodal dissection in the intrachoracic staging of patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg 117: 246–251.

    Article  PubMed  CAS  Google Scholar 

  11. Gralla RJ, Cole JT, Robertson CN, et al. (1997) Docetaxel plus cisplatin: An active combination regimen in non-small cell lung cancer. Oncology 11: 27–30.

    Google Scholar 

  12. Hara N, Ohta M, Ichinose Y, Motohiro A, Kuda T, Asoh H, Kawasaki M (1997) Influence of surgical resection before and after chemotherapy on survival in small-cell lung cancer. J Surg Oncol 47: 53–61.

    Article  Google Scholar 

  13. Hassenstein EOM (1997) Strahlentherapie beim Bronchialcarcinom: Was ist Routine, was ist neu? Atemw Lungenkrkh 23: 322–326.

    Google Scholar 

  14. Häussinger K, Weeg O, Kohlhäufl M (1997) Bronchialcarcinom: Was ist an Diagnostik unabdingbar, was ist überflüssig? Atemw Lungenkrkh 23: 308–315.

    Google Scholar 

  15. Herse B, Dalichau H, Wörmann B, Hemmerlein B, Schmidberger H, Hess CF, Hannemann P, Criee CP, Hiddemann W, Griesinger F (1998) Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small cell lung cancer. Thorac Cardiovasc Surg 46: 298–302.

    Article  PubMed  CAS  Google Scholar 

  16. Holoye PY, Shirinian M (1991) Adjuvant surgery in the multimodality treatment of small-cell lung cancer. Am J Clin Oncol 14: 251–253.

    Article  PubMed  CAS  Google Scholar 

  17. Jansen HJ, Zeidler D (1999) Die lungenfunktionelle Abklärung des pulmonalen Rcsektionsumfanges in der Thoraxchirurgie. Atemw Lungenkrkh 25: 138–150.

    Google Scholar 

  18. Kandiolcr-Eckersberger D, Kappel S, Mittclböck M, Dekan G, Ludwig C, Janschek E, Pirker R, Wolner E, Eckersberger F (1999) The TP53 genotype but not immunohistochemical results is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer. J Thorac Cardiovasc Surg 117: 744–750.

    Article  Google Scholar 

  19. Kandioler D, Födinger M, Müller MR, Mannhalter Ch, Eckersberger F, Wolner E (1994) Carcinogenic specifity of p53 tumor suppressor gene mutations in lung cancer. J Thorac Cardiovasc Surg 107: 1095–1098.

    PubMed  CAS  Google Scholar 

  20. Keenan RJ, Landreneau RJ, Mack MJ (1998) Videoassisted thoracoscopy for the diagnosis and management of pleural diseases. Am Rev Respir Dis 147: 737 A.

    Google Scholar 

  21. Kris MG (1998) What does chemotherapy have to offer patients with advances-stage non-small cell lung cancer? Semin Oncol 25/3(Suppl 8): 1–4.

    Google Scholar 

  22. Koniezko N, Ferlinz R, Loddenkemper R, Magnussen H, Toomes H, Schlimmer P, Wiehert W (1994) Empfehlungen zur praeoperativen Lungenfunktionsdiagnostik. Deutsche Gesellschaft für Pneumologie. Pneumologie 48: 296–299.

    Google Scholar 

  23. Landreneau RJ, Mack MJ, Dowling RD, Liketisch JD, Keenan RJ, Ferson PF, Hazclrigg StR (1998) The role of thoracoscopy in lung cancer management. Chest 113: 6S-12S.

    Google Scholar 

  24. Lucchi M, Mussi A, Chella A, Janni A, Ribechini A, Menconi GF, Angeletti CA (1997) Surgery in the management of small-cell lung cancer. Eur J Cardiothorac Surg 12: 689–693.

    Article  PubMed  CAS  Google Scholar 

  25. Macchiarini P, Hardin M, Basolo F, Bruno J, Chella A, Angeletti CA (1991) Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer. Am J Clin Oncol 4:218–224.

    Article  Google Scholar 

  26. Mathisen DJ, Wain JC, Wright C, et al. (1996) Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small cell lung cancer. J Thorac Cardiovasc Surg 111: 123–133.

    Article  PubMed  CAS  Google Scholar 

  27. McCaughan BD (1994) Primary lung cancer invading the chest wall. Surg Clin North Am 4: 17–28.

    CAS  Google Scholar 

  28. Mountain CF (1997) A new international staging system for lung cancer. Chest 89: 225 S-233 S.

    Google Scholar 

  29. Muller LC, Salzer GM, Huber LC, Prior C, Ebner I, Frommhold H, Prauer HW (1992) Multimodality treatment of small-cell lung cancer in TNM stages I through Ilia. Ann Thorac Surg 54: 493–497.

    Article  PubMed  CAS  Google Scholar 

  30. Offical Statement of the American Thoracic Society and the European Respiratory Society (1997) Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Mcd 156: 320–332.

    Google Scholar 

  31. Pani S, McKelvey A, Riordan Ch, Federico JA, Ponn RB (1998) Pulmonary esection for malignancy in the elderly: Is age still a risk factor? Eur J Cardiothoracic Surg 14: 40–45.

    Article  Google Scholar 

  32. Pifarre A, Rosell R, Monzo M, et al. (1997) Prognostic value of replication errors on chromosomes 2p and 3p in non-small cell lung cancer. Br J Cancer 75: 184–189.

    Article  PubMed  CAS  Google Scholar 

  33. Van Raemdonck DE, Schneider A, Ginsberg RJ (1992) Surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg 54: 999–1013.

    Article  PubMed  Google Scholar 

  34. Rea F, Loy M, Bortolotti L, Feltracco P, Fiore D, Sartori F (1997) Morbidity, mortality and survival after bronchoplastic procedures for lung cancer. Eur J Cardiothorac Surg 11: 201–205.

    Article  PubMed  CAS  Google Scholar 

  35. Rendina EA, Venuta F, De Giacomo T, Ciccone AM, Ruvolo G, Coloni GF, Ricci C (1999) Induction chemotherapy for T4 centrally located non-small cell lung cancer. J Thorac Cardiovasc Surg 117: 225–233.

    Article  PubMed  CAS  Google Scholar 

  36. Richter LK, Sendsen UG, Milman N, Brenoe J, Petersen BN (1997) Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J 10: 1559–1565.

    Article  Google Scholar 

  37. Rosell R (1998) The integration of newer agent into neoadjuvant therapy. Semin Oncol 25: 24–27.

    PubMed  CAS  Google Scholar 

  38. Rosell R, Gomez-Codina J, Camps C (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153–158.

    Article  PubMed  CAS  Google Scholar 

  39. Rush V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, et al. (1995) Aberrant p53 expression predicts clinical resistance to cisplatinum-based chemotherapy in local advanced non-small cell lung cancer. Cancer Res 55: 5038–5042.

    Google Scholar 

  40. Sause W, Scott C, Taylor S, et al. (1995) Induction chemotherapy plus radiation in NSCLC. J Natl Cancer Inst 87: 198–205.

    Article  PubMed  CAS  Google Scholar 

  41. Vansteenkist J, De Leyn P, Deneffe G, Menten J, Lerut T, Demedts M, The Leuven Cancer Group (1998) Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: A review. Eur J Cardiothorac Surg 13: 1–12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Herz- und Thoraxchirurgie, Universitatsklinik für Chirurgie, Wahringer Gürtel 18-20, A-1090, Wien

    Prof. Dr. Franz Eckersberger

Authors
  1. Prof. Dr. Franz Eckersberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Abteilung für Onkologie, Univ.-Klinik für Innere Medizin I Allgemeines Krankenhaus, Wien, Österreich

    Christoph Zielinski

  2. Klinische Abteilung für Allgemeinchirurgie, Univ.-Klinik für Chirurgie Allgemeines Krankenhaus, Wien, Österreich

    Raimund Jakesz

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Wien

About this chapter

Cite this chapter

Eckersberger, F. (2000). Chirurgie. In: Zielinski, C., Jakesz, R. (eds) Bronchuscarcinom. Onkologie heute. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6336-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6336-8_4

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83393-3

  • Online ISBN: 978-3-7091-6336-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation